EDGAR Filing Documents for 0001213900-24-099646

Form F-3/A - Registration statement by foreign private issuers: [Amend]

SEC Accession No. 0001213900-24-099646

Filing Date

2024-11-18

Accepted

2024-11-18 16:12:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM F-3	ea0221572-f3a1_nlspharm.htm	F-3/A	879298
2	CONSENT OF PRICEWATERHOUSECOOPERS AG	ea022157201ex23-1_nlsphar.htm	EX-23.1	2396
3	CONSENT OF KOST FORRER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL	ea022157201ex23-3_nlsphar.htm	EX-23.3	3884
4	GRAPHIC	ex23-3_001.jpg	GRAPHIC	2148
5	GRAPHIC	image_001.jpg	GRAPHIC	2670
6	GRAPHIC	image_002.jpg	GRAPHIC	38871
7	GRAPHIC	image_003.jpg	GRAPHIC	99109
8	GRAPHIC	image_004.jpg	GRAPHIC	181842
9	GRAPHIC	image_005.jpg	GRAPHIC	96898
10	GRAPHIC	image_006.jpg	GRAPHIC	107007
11	GRAPHIC	image_007.jpg	GRAPHIC	159633
12	GRAPHIC	image_008.jpg	GRAPHIC	135879
13	GRAPHIC	image_009.jpg	GRAPHIC	105445
14	GRAPHIC	image_010.jpg	GRAPHIC	91554
15	GRAPHIC	image_011.jpg	GRAPHIC	254435
16	GRAPHIC	image_012.jpg	GRAPHIC	155850
17	GRAPHIC	image_013.jpg	GRAPHIC	161473
18	GRAPHIC	image_014.jpg	GRAPHIC	122707
19	GRAPHIC	image_015.jpg	GRAPHIC	167627
	Complete submission text file	0001213900-24-099646.txt		3482306

Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370

Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00

NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)